Vendor, Doylestown, PA
Merlin Biotech Inc.
UEI U33SZN8R3966, CAGE 9K6A1
1 award and $300,000 obligated between September 16, 2025 and August 20, 2026, 100% under full and open competition, against 55.0 offers on average where reported. 2 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $300,000 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Hear when Merlin Biotech Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Merlin Biotech Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- $300,000
- Soonest
- September 21, 2027
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) to National Institutes of Health, by dollars.
| Leidos Biomedical Research Inc.Frederick, MD | $2,186,453,292 |
| Westat, Inc.Rockville, MD | $762,955,645 |
| Technical Resources International, Inc.Bethesda, MD | $196,391,189 |
| Duke UniversityDurham, NC | $158,758,507 |
| MriglobalKansas City, MO | $117,921,746 |
| The Johns Hopkins UniversityBaltimore, MD | $100,932,043 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91025C00025Definitive Contract, September 16, 2025, Full and Open Competition After Exclusion of Sources, 55 offersSolicitation | NIH NCINational Institutes of Health | SBIR FY25 Concept Award, Development of an Immunotherapy for Ewing Sarcoma Using a Novel Murine ModelNAICS 541715, PSC AN12 | $300,000 |
- Places of performance
- Pennsylvania
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 2 across 1 awards